comparemela.com

Latest Breaking News On - Forum on neuroscience - Page 2 : comparemela.com

Technology Being Challenged by Upsurge in Decentralized Clinical Trials

Delix Therapeutics Announces Appointment of Dr. John Krystal to Scientific & Strategic Advisory Board

/PRNewswire/ Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for serious psychiatric and.

Boston
Massachusetts
United-states
Mark-rus
Timothy-regan
Abby-berger
Davide-olson
John-krystal
Robertl-mcneil-jr
Professor-of-translational-research
Yale-center
National-academy-of-medicine

Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships

Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. Estimates show that more than 11 percent of the American population suffer from chronic pain, yet the federal pain research investment has been minimal. In parallel with a gradual increased recognition of the problems of treating chronic pain, the opioid epidemic has emerged as a growing public health emergency. The intersection of these two crises lies in the fact that an unintended consequence of treating pain has been an increasing number of opioid prescriptions and diversion of drugs for illicit purposes.

Washington
United-states
Board-on-health-sciences
Therapeutic-development-for-pain
Cover-of-advancing-therapeutic-development-for-pain
Medicine-division
National-academy-of-sciences
National-academies-press
National-academies-of-sciences
Forum-on-neuroscience
Advancing-therapeutic-development

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.